These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 20029960

  • 1. The inhibitory effects of rosiglitazone on cardiac hypertrophy through modulating the renin-angiotensin system in diet-induced hypercholesterolemic rats.
    Ren L, Li Y, Li Y, Tang R, Hu D, Sheng Z, Liu N.
    Cell Biochem Funct; 2010 Jan; 28(1):58-65. PubMed ID: 20029960
    [Abstract] [Full Text] [Related]

  • 2. Vasculoprotective effects of rosiglitazone through modulating renin-angiotensin system in vivo and vitro.
    Ren L, Liu N, Zhi H, Li Y, Li Y, Tang R, Sheng Z.
    Cardiovasc Diabetol; 2011 Jan 26; 10():10. PubMed ID: 21269478
    [Abstract] [Full Text] [Related]

  • 3. Cardiac protective effects of irbesartan via the PPAR-gamma signaling pathway in angiotensin-converting enzyme 2-deficient mice.
    Zhang ZZ, Shang QH, Jin HY, Song B, Oudit GY, Lu L, Zhou T, Xu YL, Gao PJ, Zhu DL, Penninger JM, Zhong JC.
    J Transl Med; 2013 Sep 25; 11():229. PubMed ID: 24067190
    [Abstract] [Full Text] [Related]

  • 4. Expression of renin-angiotensin system and peroxisome proliferator-activated receptors in alcoholic cardiomyopathy.
    Jing L, Li WM, Zhou LJ, Li S, Kou JJ, Song J.
    Alcohol Clin Exp Res; 2008 Nov 25; 32(11):1999-2007. PubMed ID: 18783396
    [Abstract] [Full Text] [Related]

  • 5. Cardiac and renal protective effects of irbesartan via peroxisome proliferator-activated receptorγ-hepatocyte growth factor pathway independent of angiotensin II Type 1a receptor blockade in mouse model of salt-sensitive hypertension.
    Kusunoki H, Taniyama Y, Rakugi H, Morishita R.
    J Am Heart Assoc; 2013 Apr 22; 2(2):e000103. PubMed ID: 23608606
    [Abstract] [Full Text] [Related]

  • 6. Angiotensin II enhances integrin and alpha-actinin expression in adult rat cardiac fibroblasts.
    Kawano H, Cody RJ, Graf K, Goetze S, Kawano Y, Schnee J, Law RE, Hsueh WA.
    Hypertension; 2000 Jan 22; 35(1 Pt 2):273-9. PubMed ID: 10642310
    [Abstract] [Full Text] [Related]

  • 7. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro.
    Kojima M, Shiojima I, Yamazaki T, Komuro I, Zou Z, Wang Y, Mizuno T, Ueki K, Tobe K, Kadowaki T.
    Circulation; 1994 May 22; 89(5):2204-11. PubMed ID: 8181146
    [Abstract] [Full Text] [Related]

  • 8. Cardioprotective effects of rosiglitazone are associated with selective overexpression of type 2 angiotensin receptors and inhibition of p42/44 MAPK.
    Molavi B, Chen J, Mehta JL.
    Am J Physiol Heart Circ Physiol; 2006 Aug 22; 291(2):H687-93. PubMed ID: 16582019
    [Abstract] [Full Text] [Related]

  • 9. Comparison of irbesartan with captopril effects on cardiac hypertrophy and gene expression in heart failure-prone male SHHF/Mcc-fa(cp) rats.
    Carraway JW, Park S, McCune SA, Holycross BJ, Radin MJ.
    J Cardiovasc Pharmacol; 1999 Mar 22; 33(3):451-60. PubMed ID: 10069682
    [Abstract] [Full Text] [Related]

  • 10. Role of the renin-angiotensin system in cardiac hypertrophy.
    Yamazaki T, Komuro I, Yazaki Y.
    Am J Cardiol; 1999 Jun 17; 83(12A):53H-57H. PubMed ID: 10750588
    [Abstract] [Full Text] [Related]

  • 11. PPAR gamma agonists partially restores hyperglycemia induced aggravation of vascular dysfunction to angiotensin II in thoracic aorta isolated from rats with insulin resistance.
    Gaikwad AB, Viswanad B, Ramarao P.
    Pharmacol Res; 2007 May 17; 55(5):400-7. PubMed ID: 17369046
    [Abstract] [Full Text] [Related]

  • 12. Renin-angiotensin system and myocardial collagen matrix: modulation of cardiac fibroblast function by angiotensin II type 1 receptor antagonism.
    Brilla CG, Scheer C, Rupp H.
    J Hypertens Suppl; 1997 Dec 17; 15(6):S13-9. PubMed ID: 9493122
    [Abstract] [Full Text] [Related]

  • 13. Long-term angiotensin II AT1 receptor inhibition produces adipose tissue hypotrophy accompanied by increased expression of adiponectin and PPARgamma.
    Zorad S, Dou JT, Benicky J, Hutanu D, Tybitanclova K, Zhou J, Saavedra JM.
    Eur J Pharmacol; 2006 Dec 15; 552(1-3):112-22. PubMed ID: 17064684
    [Abstract] [Full Text] [Related]

  • 14. Molecular mechanisms of irbesartan suppressing atherosclerosis in high cholesterol-diet apolipoprotein E knock-out mice.
    Yao R, Cheng X, Chen Y, Xie JJ, Yu X, Liao MY, Ding YJ, Tang TT, Liao YH.
    Int J Cardiol; 2010 Mar 04; 139(2):113-22. PubMed ID: 19028402
    [Abstract] [Full Text] [Related]

  • 15. Involvement of the renin-angiotensin system in the development of vascular damage in a rat model of arthritis: effect of angiotensin receptor blockers.
    Sakuta T, Morita Y, Satoh M, Fox DA, Kashihara N.
    Arthritis Rheum; 2010 May 04; 62(5):1319-28. PubMed ID: 20213806
    [Abstract] [Full Text] [Related]

  • 16. The renin-angiotensin system and volume overload-induced cardiac hypertrophy in rats. Effects of angiotensin converting enzyme inhibitor versus angiotensin II receptor blocker.
    Ruzicka M, Yuan B, Harmsen E, Leenen FH.
    Circulation; 1993 Mar 04; 87(3):921-30. PubMed ID: 8443912
    [Abstract] [Full Text] [Related]

  • 17. AT1 receptor participates in the cardiac hypertrophy induced by resistance training in rats.
    Barauna VG, Magalhaes FC, Krieger JE, Oliveira EM.
    Am J Physiol Regul Integr Comp Physiol; 2008 Aug 04; 295(2):R381-7. PubMed ID: 18495827
    [Abstract] [Full Text] [Related]

  • 18. PPARγ activation improves the molecular and functional components of I(to) remodeling by angiotensin II.
    Nanayakkara G, Viswaprakash N, Zhong J, Kariharan T, Quindry J, Amin R.
    Curr Pharm Des; 2013 Aug 04; 19(27):4839-47. PubMed ID: 23323617
    [Abstract] [Full Text] [Related]

  • 19. PPARgamma-activating angiotensin type-1 receptor blockers induce adiponectin.
    Clasen R, Schupp M, Foryst-Ludwig A, Sprang C, Clemenz M, Krikov M, Thöne-Reineke C, Unger T, Kintscher U.
    Hypertension; 2005 Jul 04; 46(1):137-43. PubMed ID: 15939809
    [Abstract] [Full Text] [Related]

  • 20. Angiotensin AT2 receptor contributes to cardiovascular remodelling of aged rats during chronic AT1 receptor blockade.
    Jones ES, Black MJ, Widdop RE.
    J Mol Cell Cardiol; 2004 Nov 04; 37(5):1023-30. PubMed ID: 15522279
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.